Table 1.
Clinical and biochemical characteristics of the study population
| Variables | Population | P | |
|---|---|---|---|
| Nonobese (n=169) | Obese (n=160) | ||
| Age (y) | 43.25±13.12 | 48.41±10.92 | <.001 |
| Sex‐ratio (men/women) | 0.594 | 0.221 | .001 |
| Smoking n (%) | 29 (17.2) | 11 (6.9) | .004 |
| Weight (kg) | 66.94±11.29 | 93.60±12.97 | <.001 |
| BMI (kg/m2) | 24.73±3.50 | 36.6±4.8 | <.001 |
| WC (cm) | 89.09±13.67 | 117.85±12.61 | <.001 |
| Hypertension n (%) | 23 (13.6) | 72 (45.3) | <.001 |
| Diabetes n (%) | 32 (18.9) | 54 (34) | .002 |
| Cardiovascular disease n (%) | 0 (0) | 22 (14) | <.001 |
| Dyslipidemia n (%) | 82 (48.5) | 78 (49.1) | .923 |
| MetS n (%) | 20 (12) | 77 (48.1) | <.001 |
| Fasting insulin (μU/mL) | 6.27 [0.7‐27.3] | 8.2 [0.4‐81.7] | <.001 |
| HOMA‐IR | 1 [0.14‐5.08] | 2,32 [0.11‐40.6] | <.001 |
| TC (mmol/L) | 4.75±1.1 | 5.17±1.25 | <.001 |
| TG (mmol/L) | 0,86 [0.24‐4.69] | 1,2 [0.23‐3.95] | <.001 |
| HDL‐C (mmol/L) | 1.31±0.49 | 1.13±0.34 | .009 |
| LDL‐C (mmol/L) | 3.27±0.94 | 3.24±0.99 | .262 |
| Coffee consumption n (%) | 125 (74.2) | 98 (61.5) | .009 |
| Daily energy intake (kcal) | 3092±1541 | 3204±1333 | .636 |
| Resistin level (ng/mL) | 11.07 [0.1‐28.5] | 14.34 [0.1‐96] | .019 |
BMI, body mass index; HOMA‐IR, homeostasis assessment model insulin resistance; TC, total cholesterol; TG, triglyceride; HDL‐C, high density lipoprotein‐cholesterol; LDL, low density lipoprotein‐cholesterol; MetS, metabolic syndrome; WC, waist circumference.
Mean±standard deviation or n (%).